Design and Discovery of Small Molecules Targeting Raf-1 Kinase

Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2269-2278
Author(s): Timothy B. Lowinger, Bernd Riedl, Jacques Dumas, Roger A. Smith

BAY 43-9006: Preclinical Data

Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2255-2257
Author(s): Scott Wilhelm, Du-Shieng Chien

Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 1 Year: 2010 Page: 120-127
Author(s): Sarah Burgess, Valentina Echeverria

Pharmacophore and Binding Analysis of Known and Novel B-RAF Kinase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 21 Issue: 17 Year: 2014 Page: 1938-1955
Author(s): F. Baska,I. Szabadkai,A. Sipos,N. Breza,C. Szantai-Kis,L. Kekesi,R. Garamvolgyi,Z. Nemes,F. Baska,L. Neumann,R. Torka,A. Ullrich,G. Keri,L. Orfi

Development of Sorafenib in Malignant Gliomas: Rationale and Early Clinical Experience

Ebook: Controversies in Neuro-Oncology
Volume: 1 Year: 2010
Author(s): Rachel Grossman, Jaishri Blakeley
Doi: 10.2174/978160805132811001010162

AIDS Related Viruses, their Association with Leukemia, and Raf Signaling

Journal: Current HIV Research
Volume: 3 Issue: 4 Year: 2005 Page: 319-327
Author(s): Audy G. Whitman, Benjaman A. Bryan, Ossie F. Dyson, Dipali K. Patel, Dan Ramasamy, Senthilvelan Anantharaman, Adrian J. Reber, Shaw M. Akula

A Fluoro Derivative of Embelin, as Potent B-RAF Inhibitor in Melanoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 15 Year: 2021 Page: 2066-2074
Author(s): Arunkumar Babu,Shiny P. Laila,Annette Fernandez

Journal: Current Signal Transduction Therapy
Volume: 5 Issue: 2 Year: 2010 Page: 149-160
Author(s): Judith-Irina Pagel, Elisabeth Deindl

Endothelin Signalling in the Cardiac Myocyte and its Pathophysiological Relevance

Journal: Current Vascular Pharmacology
Volume: 3 Issue: 4 Year: 2005 Page: 343-351
Author(s): Peter H. Sugden, Angela Clerk

Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19 Issue: 5 Year: 2019 Page: 697-706
Author(s): Hany A.M. El-Sherief,Bahaa G.M. Youssif,Ahmed H. Abdelazeem,Mohamed Abdel-Aziz,Hamdy M. Abdel-Rahman